ABSOLV3
Live / Registered — Registered (as of 22 Sept 2026)
What this means for you
Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 98529028
- Registration number
- 8451523
- Mark type
- Word mark
- Filed
- 01 May 2024
- Published for opposition
- 10 Dec 2024
- Registered
- 22 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic products, namely, amniotic patches applied to the skin that are derived from human amnion for implantation and for topical treatment all to promote healing and rejuvenation of wounded bodily tissue; Therapeutic products, namely, amniotic patches applied to internal organs and bodily tissues that are derived from human amnion for implantation and for topical treatment all to promote healing and rejuvenation of wounded bodily tissue
Owner
- Amnio Technology, LLC, Phoenix, AZ, US
- Amnio Technology, LLC, Phoenix, AZ, US
- Amnio Technology, LLC, Phoenix, AZ, US
Prosecution history
- 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 28 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Aug 2026 — ASSIGNED TO LIE
- 25 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Apr 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 24 Apr 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 01 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jul 2025 — USE AMENDMENT FILED
- 01 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL